Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Biogen
Biogen
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio
Why Biogen's Recent Rebound May Not Last -- at Least for Now
Motley Fool
Wed, 11/27/19 - 10:43 am
Biogen
MS
multiple sclerois
Alzheimer's disease
Tecfidera
aducanumab
Roche, PTC will now get an FDA decision on their SMA drug in 6 months — facing off with Biogen, Novartis
Endpoints
Mon, 11/25/19 - 09:52 am
Roche
PTC Therapeutics
SMA
risdiplam
Biogen
Spinraza
Patient charity to pay $4M to settle kickback allegations
Beckers Hospital Review
Fri, 11/22/19 - 10:12 am
kickbacks
Medicare
Medicare fraud
MS
multiple sclerosis
Teva Pharmaceutical
Biogen
Novartis
Biogen’s top scientist nearly dares FDA not to approve Alzheimer’s drug
Stat
Thu, 11/21/19 - 11:20 pm
Biogen
aducanumab
FDA
Alzheimer's disease
Novartis, Merck KGaA and Biogen: Which new MS drug do doctors like best? You might be surprised
Fierce Pharma
Tue, 11/19/19 - 02:41 pm
MS
multiple sclerosis
physicians
Novartis
Mayzent
Merck KGaA
Mavenclad
Biogen
Vumerity
Vumerity’s $88,000 List Price Not What ‘We Had Hoped,’ National MS Society Says
Multiple Sclerosis News Today
Thu, 11/14/19 - 07:35 pm
Biogen
MS
multiple sclerosis
Vumerity
drug pricing
Tecfidera
Roche sets sights on Novartis, Biogen as SMA trial hits target
Yahoo/Reuters
Mon, 11/11/19 - 10:49 am
Roche
SMA
risdiplam
Biogen
Novartis
clinical trials
DEAL WATCH: Biosimilars, Biosimilars and More Biosimilars
Big Molecule Watch
Sun, 11/10/19 - 07:55 pm
biosimilars
Henlius
Ascentage
rituximab
Bioeq
Alvotech
Coherus
Biogen
Samsung Bioepis
Here's Why Biogen Stock Shot Up 28% in October
Motley Fool
Sun, 11/10/19 - 07:51 pm
Biogen
Alzheimer's disease
aducanumab
Biogen hit back at whistleblowing sales manager, jury finds, levying $6M in damages
Fierce Pharma
Fri, 11/8/19 - 10:54 am
Biogen
whistleblower lawsuit
retaliation claims
False Claims Act
Biogen signs marketing deal for two ophthalmology biosimilars
Pharmaforum
Thu, 11/7/19 - 10:16 am
Biogen
ophthalmology
biosimilars
Europe
Japan
Samsung Bioepis
SB11
SB15
Lucentis
Eylea
Biogen ups investment in biosimilars
Marketwatch
Wed, 11/6/19 - 10:20 am
Biogen
biosimilars
Samsung Bioepis
Biogen, Alkermes win FDA approval of Tecfidera successor — but can they actually sell it?
Endpoints
Wed, 10/30/19 - 10:13 am
Biogen
Alkermes
FDA
multiple sclerosis
MS
Vumerity
Biogen Alzheimer's Case Shows Danger of Trials Killing Good Drugs
Yahoo/Guru Focus
Mon, 10/28/19 - 11:09 pm
Biogen
Alzheimer's disease
aducanumab
clinical trials
drug development
2 Biotech Stocks That Soared Last Week
Motley Fool
Mon, 10/28/19 - 10:34 am
Biogen
Arvinas
aducanumab
protein degradation
ARV-110
More Details Emerge on Biogen’s Alzheimer’s Comeback
BioSpace
Mon, 10/28/19 - 10:31 am
Biogen
Alzheimer's disease
aducanumab
An Alzheimer’s patient on what was lost when Biogen shut down its trial, and what may be gained again
Stat
Fri, 10/25/19 - 10:40 am
Biogen
patients
Alzheimer's disease
aducanumab
clinical trials
Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data
Bloomberg
Wed, 10/23/19 - 10:29 pm
Eli Lilly
Biogen
Alzheimer's disease
David Ricks
Biogen's Stock Could More Than Quadruple in Value in 5 Years
Motley Fool
Wed, 10/23/19 - 10:08 am
Biogen
biotech stocks
aducanumab
Alzheimer's disease
Pages
« first
‹ previous
…
24
25
26
27
28
29
30
31
32
…
next ›
last »